InsidersTradesSigma
健帆生物 Stock: price and directors' dealings · China · SSE / SZSE (CSRC)
Track the 健帆生物 stock price and the full insider trade history of the company, a listed issuer based in China. Shares trade on CN CN, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 健帆生物 has logged 6 public disclosures. Market capitalisation: €15.7bn. The latest transaction was reported on 13 January 2023 (Sale). Among the most active insiders: 何小莲. The full history is openly available.
6
Insider Decl.
0
Thresholds
·
2 ops.
Buy Volume
·
4 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 6,065 of 25,973 companies
65.0
score / 100
Value50
Quality80
FCF yld4.2%
Earn yld4.1%
EV/EBITDA17.0x
ROE16%
Gross mgn79%
Net mgn26%
Debt/EBITDA1.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 13 January 2023
Declarations6 total
6 of 6 declarations